25 June 2009 - Biotica adds nPT-CyP, a series of polyketide cyclophilin inhibitors for HCV, to its pipeline
Biotica expands its development-track pipeline with nPT-CyP, a non-cyclosporin cyclophilin inhibitor for HCV
26 May 2009 - Dr Alan Lewis joins Biotica Board
Biotica today announced the appointment of Dr Alan Lewis as a Non-Executive Director
12 January 2009 - Biotica strikes significant collaboration deal with GlaxoSmithKline
GSK and Biotica collaborate to discover & develop novel erythromycin macrolides
12 September 2007 - Biotica appoints Edward E. Hodgkin as CEO
Biotica announced today the appointment of Edward E. Hodgkin as Chief Executive Officer and Director.
05 September 2007 - Dr Peter Ringrose joins Biotica Board
Biotica today announced the appointment of Dr Peter Ringrose to its Board of Directors
Biotica expands its development-track pipeline with nPT-CyP, a non-cyclosporin cyclophilin inhibitor for HCV
26 May 2009 - Dr Alan Lewis joins Biotica Board
Biotica today announced the appointment of Dr Alan Lewis as a Non-Executive Director
12 January 2009 - Biotica strikes significant collaboration deal with GlaxoSmithKline
GSK and Biotica collaborate to discover & develop novel erythromycin macrolides
12 September 2007 - Biotica appoints Edward E. Hodgkin as CEO
Biotica announced today the appointment of Edward E. Hodgkin as Chief Executive Officer and Director.
05 September 2007 - Dr Peter Ringrose joins Biotica Board
Biotica today announced the appointment of Dr Peter Ringrose to its Board of Directors